Skip to content

Clinical trials

Phase 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Precursor Cell Lymphoblastic Leukemia-Lymphoma Phase: Phase 2 Country / region: Italy Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20032
20042
20053
20061
20072
20081
20102
20111
20123
20131
20144
20151
20172
20182
20193
20202
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Unknown status5
Active, not recruiting4
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gruppo Italiano Malattie EMatologiche dell'Adulto11
Fred Hutchinson Cancer Center4
Novartis Pharmaceuticals4
Amgen Research (Munich) GmbH2
Amgen1
Bristol-Myers Squibb1
Charite University, Berlin, Germany1
European Organisation for Research and Treatment of Cancer - EORTC1
Fondazione Matilde Tettamanti Menotti De Marchi Onlus1
Genzyme, a Sanofi Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Precursor Cell Lymphoblastic Leukemia-Lymphoma41
Leukemia, Myeloid, Acute11
Recurrence7
Burkitt Lymphoma6
Leukemia, Lymphocytic, Chronic, B-Cell6
Multiple Myeloma6
Hodgkin Disease5
Leukemia5
Lymphoma, Non-Hodgkin5
Waldenstrom Macroglobulinemia5

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.